Skip to main content
Premium Trial:

Request an Annual Quote

Applied Biosystems, Premier Biosoft Collaborate on Glycomics Research Tools

NEW YORK (GenomeWeb News) – Applied Biosystems and its mass spectrometry joint venture partner, MDS Analytical Technologies, will collaborate with bioinformatics firm Premier Biosoft to develop integrated workflows for glycomics researchers, ABI said today.
Under the alliance, ABI and MDS will co-market and resell Premier Biosoft’s SimGlycan, a high-throughput glycan mass finger-printing tool, for use with their mass spectrometers including the 4800 Plus MALDI TOF/TOF Analyzer, the 4000 QTrap System, and the QStar Elite System. The SimGlycan predicts glycan structure using MS/MS data acquired by mass spectrometry.
"Protein glycosylation is one of the most common types of post-translational modifications," Lydia Nuwaysir, senior product manager at ABI, said in a statement. "Full characterization is particularly important for biopharmaceuticals because, ultimately, the type and extent of glycosylation can affect protein structure and activity.”
Terms of the alliance were not disclosed.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.